BridgeBio Pharma, Inc. (BBIO)
SEC filings, insider trading & institutional ownership from EDGAR.
Institutions
44
$8.38B held
Latest filings
10-K, 10-Q, 8-K, Form 4 & 13D/G. Sourced directly from SEC EDGAR
No filings are available yet.
Top holders
13F & 13D/G · latest quarter
| Holder | Filed | Value |
|---|---|---|
| BlackRock, Inc. | Aug 7, 2026 | $766.19M |
| VIKING GLOBAL INVESTORS LP | Aug 14, 2026 | $741.02M |
| Vanguard Capital Management | Aug 13, 2026 | $588.32M |
| Vanguard Portfolio Management | Aug 13, 2026 | $570.27M |
| JANE STREET GROUP, LLC | Aug 14, 2026 | $455.33M |
BBIO's filings are public. The insight is one click away.
Scrutar's AI reads every BBIO filing and surfaces what matters. Red flags, risk shifts, disclosure quality and key relationships. Cited to the source, free with an account.
Red Flag Detection20+ forensic checks per filingRisk RadarYear-over-year changes in risk factorsFiling DNADisclosure quality scored across six dimensionsSupply Chain GraphCustomers, suppliers & competitors mapped
Analyze BBIO filingsNo credit cardAI reports included on the free plan
Never miss a BBIO filing.
Get an email when BBIO files its next 8-K, Form 4, 10-K or 10-Q with the SEC. Free, no account needed.
Free foreverNo account requiredOne-click unsubscribe
Data as of Aug 29, 2026Source: SEC EDGAR.